LTGO (Latigo Biotherapeutics) Beneish M-Score

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTGO Latigo Biotherapeutics Inc LTGO
8 GF Score
Price $18.56
View Full Analysis

What is Latigo Biotherapeutics Beneish M-Score?

Latigo Biotherapeutics does not have enough data to calculate Beneish M-Score.

Latigo Biotherapeutics Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Latigo Biotherapeutics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Latigo Biotherapeutics Beneish M-Score Chart

Latigo Biotherapeutics Annual Data
Trend Dec24 Dec25
Beneish M-Score
0.00 0.00

Latigo Biotherapeutics Semi-Annual Data
Dec24 Dec25
Beneish M-Score 0.00 0.00

LTGO vs : Beneish M-Score Comparison

For the Biotechnology subindustry, Latigo Biotherapeutics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Latigo Biotherapeutics Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Latigo Biotherapeutics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Latigo Biotherapeutics's Beneish M-Score falls into.


LTGO
8GF Score
Latigo Biotherapeutics Inc LTGO
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Latigo Biotherapeutics Business Description

Comparable Companies
Address 1300 Rancho Conejo Boulevard, Suite 305, Thousand Oaks, CA, USA, 91320
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
8GF Score

Get the complete analysis for LTGO

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.56
Price